“This is a big blow to the national litigation strategy of the industry, ... This federal preemption argument was emerging as one of the industry's standard responses to all the issues. It's a main line of defense.”
“The science we have today clearly shows that this is not black and white. That we have moved now into a gray area, that suggests there could be a problem that needs to be looked at very, very carefully. That gray area needs to be acknowledged,”
“When I saw the patents I was distressed that the scientific information had not been shared with us. When they talk about health risks [in] corporate documents and then say there are no health risks...how could there be such a glaring inconsistency?”
“The amount of scrutiny and review that the WTR has undergone over the years is enormous, yet the work that was done has held up and remains critically important to safety concerns,”
“The amount of scrutiny and review that the WTR has undergone over the years is enormous, yet the work that was done has held up and remains critically important to safety concerns.”
